---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-031811"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:01:10.838162+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics prices $11.5M public offering of common stock and warrants

## Summary
- Gross proceeds ~$11.5M; net proceeds ~$10.9M after discounts and expenses.
- Offering consists of 500K shares and 1.8M pre-funded warrants, each with common warrants exercisable at $5.00 for 5 years.
- Combined price: $5.00 per share+common warrant; $4.99 per pre-funded warrant+common warrant.
- Expected to close July 1, 2024; proceeds to advance development pipeline and for working capital.

## SEC filing metadata
- accession: 0001140361-24-031811
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000114036124031811/0001140361-24-031811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000114036124031811/ny20031755x4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-031811
- JSON: https://secwatch.observer/filing/0001140361-24-031811.json
- Plain text: https://secwatch.observer/filing/0001140361-24-031811.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.